BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 4964232)

  • 1. Experimental infection with small doses of virulent Shigella flexneri 2A in cynomolgus monkeys (Macaca irus). Clinical and bacteriological observations.
    Takasaka M; Honjo S; Fujiwara T; Imaizumi K; Ogawa H
    Jpn J Med Sci Biol; 1967 Apr; 20(2):195-8. PubMed ID: 4964232
    [No Abstract]   [Full Text] [Related]  

  • 2. Shigellosis in cynomolgus monkeys (Macaca irus). V. Resistance acquired by the repetition of experimental oral infection with Shigella flexneri 2A and fluctuation of serum agglutinin titer.
    Honjo S; Takasaka M; Fujiwara T; Kaneko M; Imaizumi K
    Jpn J Med Sci Biol; 1967 Aug; 20(4):341-8. PubMed ID: 4966140
    [No Abstract]   [Full Text] [Related]  

  • 3. SHIGELLOSIS IN CYNOMOLGUS MONKEYS (MACACA IRUS). II. EXPERIMENTAL INFECTION WITH SHIGELLA FLEXNERI 2A WITH SPECIAL REFERENCES TO CLINICAL AND BACTERIOLOGICAL FINDINGS.
    HONJO S; TAKASAKA M; FUJIWARA T; NAKAGAWA M; ANDOO K; OGAWA H; TAKAHASHI R; IMAIZUMI K
    Jpn J Med Sci Biol; 1964 Dec; 17():307-19. PubMed ID: 14279864
    [No Abstract]   [Full Text] [Related]  

  • 4. Shigellosis in cynomolgus monkeys (Macaca irus). IV. Bacteriological and histopathological observations on the earlier stage of experimental infection with Shigella flexneri 2 A.
    Ogawa H; Honjo S; Takasaka M; Fujiwara T; Imaizumi K
    Jpn J Med Sci Biol; 1966 Feb; 19(1):22-32. PubMed ID: 4958740
    [No Abstract]   [Full Text] [Related]  

  • 5. Shigellosis in cynomolgus monkeys (Macaca irus). VII. Experimental production of dysentery with a relatively small dose of Shigella flexneri 2a in ascorbic acid deficient monkeys.
    Honjo S; Takasaka M; Fujiwara T; Imaizumi K; Ogawa H
    Jpn J Med Sci Biol; 1969 Jun; 22(3):149-62. PubMed ID: 4981384
    [No Abstract]   [Full Text] [Related]  

  • 6. Shigellosis in cynomolgus monkeys (Macaca irua). VI. The inoculation with various doses of Shigella flexneri 2a into cecal lumen.
    Takasaka M; Honjo S; Fujiwara T; Imaizumi K; Ogawa H
    Jpn J Med Sci Biol; 1968 Aug; 21(4):275-81. PubMed ID: 4974847
    [No Abstract]   [Full Text] [Related]  

  • 7. Effect of prior infection with virulent Shigella flexneri 2a on the resistance of monkeys to subsequent infection with Shigella sonnei.
    Formal SB; Oaks EV; Olsen RE; Wingfield-Eggleston M; Snoy PJ; Cogan JP
    J Infect Dis; 1991 Sep; 164(3):533-7. PubMed ID: 1869840
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bacillary dysentery in cynomolgus monkeys following the administration with Shigella flexneri 2A by the anal route.
    Takasaka M; Honjo S; Cho F; Imaizumi K; Ogawa H
    Jpn J Med Sci Biol; 1971 Dec; 24(6):379-85. PubMed ID: 5003951
    [No Abstract]   [Full Text] [Related]  

  • 9. Fluorescent-antibody and histological study of vaccinated and control monkeys challenged with Shigella flexneri.
    Formal SB; Kent TH; Austin S; Labrec EH
    J Bacteriol; 1966 Jun; 91(6):2368-76. PubMed ID: 4957617
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Experimental infection with Shigella sonnei in cynomolgus monkeys (Macaca irus).
    Takasaka M; Honjo S; Imaizumi K; Ogawa H; Nakaya R
    Jpn J Med Sci Biol; 1969 Dec; 22(6):389-93. PubMed ID: 4985548
    [No Abstract]   [Full Text] [Related]  

  • 11. Shigella flexneri infection: a histopathologic study of colonic biopsies in monkeys infected with virulent and attenuated bacterial strains.
    Kärnell A; Reinholt FP; Katakura S; Lindberg AA
    APMIS; 1991 Sep; 99(9):787-96. PubMed ID: 1892634
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The response of man to virulent Shigella flexneri 2a.
    DuPont HL; Hornick RB; Dawkins AT; Snyder MJ; Formal SB
    J Infect Dis; 1969 Mar; 119(3):296-9. PubMed ID: 5780532
    [No Abstract]   [Full Text] [Related]  

  • 13. Oral immunization of monkeys with polyvalent dysentery vaccine.
    Dhikidze EK; Kavtaradze KN; Krilova RI; Rauss K; Kétyi I; Vertényi A
    Acta Microbiol Acad Sci Hung; 1977; 24(1):7-12. PubMed ID: 412396
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of the virulence of Shigella flexneri by experimental infection of the rabbit eye.
    Cross WR; Nakamura M
    J Infect Dis; 1970 Nov; 122(5):394-400. PubMed ID: 4920324
    [No Abstract]   [Full Text] [Related]  

  • 15. Isolation and pathogenicity of provisional serovar 1621-54 of "Shigella" from imported cynomolgus monkeys.
    Takasaka M; Kono A; Kono M; Nakamura A; Sakakibara I; Honjo S
    Jpn J Med Sci Biol; 1983 Feb; 36(1):27-37. PubMed ID: 6865099
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differences in the virulence of Plasmodium knowlesi for Macaca irus (fascicularis) of Philippine and Malayan origins.
    Schmidt LH; Fradkin R; Harrison J; Rossan RN
    Am J Trop Med Hyg; 1977 Jul; 26(4):612-22. PubMed ID: 407808
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bacteriological and epidemiological approach to prophylaxy for enteric infection. IV. Experimental bladder infection of Shigella.
    Anzai H; Kubota Y; Okamoto M; Sekizuka S; Nakamura T
    Kitasato Arch Exp Med; 1971 Dec; 44(3):155-66. PubMed ID: 4949632
    [No Abstract]   [Full Text] [Related]  

  • 18. [Correlation of biochemical features and pathogenicity of Shigella. 3. Comparison of free amino acid pools in Shigella flexneri 2A strains producing and not producing keratoconjunctivitis in guinea pigs].
    Stypulkowska-Misiurewicz ; Noworyta J
    Med Dosw Mikrobiol; 1973; 25(1):31-41. PubMed ID: 4575294
    [No Abstract]   [Full Text] [Related]  

  • 19. Dysentery produced by oral administration of the colonic contents of cynomolgus monkeys infected with Shigella flexneri 2a.
    Takasaka M; Honjo S; Imaizumi K; Ogawa H
    Jpn J Med Sci Biol; 1970 Aug; 23(4):249-54. PubMed ID: 4992614
    [No Abstract]   [Full Text] [Related]  

  • 20. Vaccination with Shigella flexneri 2a conjugate induces type 2a and cross-reactive type 6 antibodies in humans but not in mice.
    Farzam N; Ramon-Saraf R; Banet-Levi Y; Lerner-Geva L; Ashkenazi S; Kubler-Kielb J; Vinogradov E; Robbins JB; Schneerson R
    Vaccine; 2017 Sep; 35(37):4990-4996. PubMed ID: 28797729
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.